Veru, Inc. (VERU)
2.61
-0.03
(-1.14%)
USD |
NASDAQ |
Aug 24, 16:00
2.61
0.00 (0.00%)
After-Hours: 19:57
Veru Shareholders Equity (Quarterly) : 28.38M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.38M |
| March 31, 2026 | 34.79M |
| December 31, 2025 | 37.12M |
| September 30, 2025 | 18.33M |
| June 30, 2025 | 15.34M |
| March 31, 2025 | 21.05M |
| December 31, 2024 | 26.63M |
| September 30, 2024 | 32.32M |
| June 30, 2024 | 37.62M |
| March 31, 2024 | 45.21M |
| December 31, 2023 | 51.60M |
| September 30, 2023 | 19.68M |
| June 30, 2023 | 21.41M |
| March 31, 2023 | 16.72M |
| December 31, 2022 | 49.10M |
| September 30, 2022 | 82.80M |
| June 30, 2022 | 116.87M |
| March 31, 2022 | 136.00M |
| December 31, 2021 | 148.00M |
| September 30, 2021 | 152.29M |
| June 30, 2021 | 154.97M |
| March 31, 2021 | 155.50M |
| December 31, 2020 | 48.75M |
| September 30, 2020 | 30.11M |
| June 30, 2020 | 41.28M |
| Date | Value |
|---|---|
| March 31, 2020 | 31.11M |
| December 31, 2019 | 29.64M |
| September 30, 2019 | 32.33M |
| June 30, 2019 | 34.74M |
| March 31, 2019 | 33.54M |
| December 31, 2018 | 36.88M |
| September 30, 2018 | 29.48M |
| June 30, 2018 | 35.87M |
| March 31, 2018 | 41.33M |
| December 31, 2017 | 44.75M |
| September 30, 2017 | 48.45M |
| June 30, 2017 | 50.80M |
| March 31, 2017 | 51.52M |
| December 31, 2016 | 53.22M |
| September 30, 2016 | 33.93M |
| June 30, 2016 | 35.51M |
| March 31, 2016 | 34.85M |
| December 31, 2015 | 34.72M |
| September 30, 2015 | 33.13M |
| June 30, 2015 | 32.38M |
| March 31, 2015 | 31.06M |
| December 31, 2014 | 29.26M |
| September 30, 2014 | 28.07M |
| June 30, 2014 | 28.97M |
| March 31, 2014 | 27.75M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Lexicon Pharmaceuticals, Inc. | 174.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.03M |
| Total Liabilities (Quarterly) | 8.651M |
| Debt to Equity Ratio | 0.0945 |
| Current Ratio | 4.423 |
| Net Debt Paydown Yield | 0.26% |